The Paragraph IV Disputes Conference is an annual event organized by the American Conference Institute (ACI) that focuses on Hatch-Waxman litigation, a critical area of pharmaceutical patent law. The 22nd Annual Paragraph IV Disputes Conference is scheduled for April 21–22, 2026, at The Times Center in New York City. This conference serves as a premier forum for stakeholders from both brand-name and generic pharmaceutical companies to discuss and strategize on the latest developments in Hatch-Waxman litigation.
Speakers(66)
Aaron Pereira
VP, Global Head of Mergers & Acquisitions at Ferring Pharmaceuticals
Aaron Pereira is the Vice President and Global Head of Mergers & Acquisitions at Ferring Pharmaceuticals.
Adam Burrowbridge
Partner at McDermott Will & Emery LLP
Adam Burrowbridge is a Partner at McDermott Will & Emery LLP.
Adam Perlman
Senior Vice President and Deputy General Patent Counsel — IP Litigation and IP Strategy at Eli Lilly and Company
Adam Perlman is the Senior Vice President and Deputy General Patent Counsel for IP Litigation and IP Strategy at Eli Lilly and Company.
Alison Hanstead
Partner at White & Case LLP
Alison Hanstead is a Partner at White & Case LLP.
Andrea Cheek
Partner at Knobbe Martens
Andrea Cheek is a Partner at Knobbe Martens.
Andrew Cochran
Partner at Cahill Gordon & Reindel LLP
Andrew Cochran is a Partner at Cahill Gordon & Reindel LLP.
Andrew Cohen
Partner at Patterson Belknap Webb & Tyler LLP
Andrew Cohen is a Partner at Patterson Belknap Webb & Tyler LLP.
Angie Verrecchio
Senior Counsel, Patent Litigation at Johnson & Johnson
Angie Verrecchio is Senior Counsel for Patent Litigation at Johnson & Johnson.
Aziz Burgy
Partner at Axinn, Veltrop & Harkrider LLP
Aziz Burgy is a Partner at Axinn, Veltrop & Harkrider LLP.
Ben Mahon
Partner at McAndrews, Held & Malloy, Ltd.
Ben Mahon is a Partner at McAndrews, Held & Malloy, Ltd.
Brian Nolan
Partner at Mayer Brown LLP
Brian Nolan is a Partner at Mayer Brown LLP.
Brian Robinson
Head Commercial IP and US IP Litigation at Novartis Pharmaceuticals Corporation
Brian Robinson leads Commercial IP and U.S. IP Litigation at Novartis Pharmaceuticals Corporation.
Chad Landmon
Partner at Polsinelli
Chad Landmon is a Partner at Polsinelli.
Colleen Tracy James
Partner at Cahill Gordon & Reindel LLP
Colleen Tracy James is a Partner at Cahill Gordon & Reindel LLP.
Corey Salsberg
Vice President, Global Head IP Affairs at Novartis
Corey Salsberg is the Vice President and Global Head of IP Affairs at Novartis.
David Abramowitz
Partner at Buchanan Ingersoll & Rooney, PC
David Abramowitz is a Partner at Buchanan Ingersoll & Rooney, PC.
David Korn
Vice President, Intellectual Property and Law at PhRMA
David Korn serves as the Vice President of Intellectual Property and Law at PhRMA.
David Silverstein
Vice President, IP & Litigation at Ani Pharmaceuticals, Inc.
David Silverstein is the Vice President of IP and Litigation at Ani Pharmaceuticals, Inc.
Derrick Brent
Former Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director at United States Patent & Trademark Office
Derrick Brent previously held the position of Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director at the USPTO.
Donna Meuth
Associate General Counsel, IP at Eisai
Donna Meuth is the Associate General Counsel for Intellectual Property at Eisai.
Dr. Amar Desai
Sr. General Manager – Global IP at Zydus Pharmaceuticals
Dr. Amar Desai is the Senior General Manager for Global IP at Zydus Pharmaceuticals.
Eberle Schultz
Senior Counsel, IP Litigation at Sumitomo Pharma America, Inc.
Eberle Schultz serves as Senior Counsel for IP Litigation at Sumitomo Pharma America, Inc.
Erin Austin
Partner at Venable LLP
Erin Austin is a Partner at Venable LLP.
Farheena Rasheed
Partner at Orrick
Farheena Rasheed is a Partner at Orrick.
Gil Voy
Global IP Litigation at Regeneron
Gil Voy handles Global IP Litigation at Regeneron.
Greg Morris
Partner at Proskauer
Greg Morris is a Partner at Proskauer.
Greta Peisch
Partner at Wiley Rein LLP
Greta Peisch is a Partner at Wiley Rein LLP.
Honorable Randall R. Rader (ret.)
Former Chief Judge at U.S. Court of Appeals for the Federal Circuit
Honorable Randall R. Rader is a retired Chief Judge of the U.S. Court of Appeals for the Federal Circuit.
Honorable Sherry R. Fallon
Magistrate Judge at United States District Court, District of Delaware
Honorable Sherry R. Fallon is a Magistrate Judge in the United States District Court for the District of Delaware.
Honorable Tonianne J. Bongiovanni
Magistrate Judge at United States District Court, District of New Jersey
Honorable Tonianne J. Bongiovanni serves as a Magistrate Judge in the United States District Court for the District of New Jersey.
Howard Suh
Partner at Fox Rothschild LLP
Howard Suh is a Partner at Fox Rothschild LLP.
James Holtom
Partner at McCarthy Tétrault LLP
James Holtom is a Partner at McCarthy Tétrault LLP.
Jamie Leeds
Vice President and Chief Patent Counsel, Hatch Waxman Litigation at Eli Lilly and Company
Jamie Leeds is the Vice President and Chief Patent Counsel for Hatch Waxman Litigation at Eli Lilly and Company.
John Molenda
Partner at Steptoe LLP
John Molenda is a Partner at Steptoe LLP.
Joshua Kresh
Research Professor and Executive Director, IPPI: The IP Policy Institute at The University of Akron School of Law
Joshua Kresh is a Research Professor and Executive Director of the IP Policy Institute at The University of Akron School of Law.
Karen Moreira
Director, Global Intellectual Property Litigation at Merck
Karen Moreira is the Director of Global Intellectual Property Litigation at Merck.
Karin Hessler
Chief Legal & Intellectual Property Officer at Association for Accessible Medicines
Karin Hessler is the Chief Legal and Intellectual Property Officer at the Association for Accessible Medicines.
Kevin Zive
Vice President – Global General Counsel and Head of Intellectual Property at Apotex Inc.
Kevin Zive is the Vice President, Global General Counsel, and Head of Intellectual Property at Apotex Inc.
Kirsten Axelsen
Life Sciences Consultant and Health Innovator Fellow at Aspen Institute
Kirsten Axelsen is a Life Sciences Consultant and Health Innovator Fellow at the Aspen Institute.
Kristi Sawert
Principal at Fish & Richardson P.C.
Kristi Sawert is a Principal at Fish & Richardson P.C.
Kurt Mathas
Partner at Winston & Strawn LLP
Kurt Mathas is a Partner at Winston & Strawn LLP.
Kurt R. Karst
Director at Hyman, Phelps & McNamara, P.C.
Kurt R. Karst is a Director at Hyman, Phelps & McNamara, P.C.
Lachlan Campbell-Verduyn
Partner at Patterson Belknap Webb & Tyler LLP
Lachlan Campbell-Verduyn is a Partner at Patterson Belknap Webb & Tyler LLP.
Maarika L. Kimbrell
Partner at Morgan Lewis LLP
Maarika Kimbrell is a Partner at Morgan Lewis LLP.
Marc Zubick
Partner at Latham & Watkins LLP
Marc Zubick is a Partner at Latham & Watkins LLP.
Marta E. Wosińska, PhD
Senior Fellow, Center on Health Policy at The Brookings Institution
Marta E. Wosińska, PhD, is a Senior Fellow at the Center on Health Policy at The Brookings Institution.
Mary Till
Of Counsel at Finnegan
Mary Till is Of Counsel at Finnegan.
Maryll Toufanian
Senior Vice President, Regulatory Strategy and Government Affairs at Amneal Pharmaceuticals
Maryll Toufanian is the Senior Vice President of Regulatory Strategy and Government Affairs at Amneal Pharmaceuticals.
Melanie R. Rupert
Partner, Global Co-Chair of Talent Development at Paul Hastings LLP
Melanie R. Rupert is a Partner and Global Co-Chair of Talent Development at Paul Hastings LLP.
Michael McCabe
Managing Partner at McCabe Ali LLP
Michael McCabe is the Managing Partner at McCabe Ali LLP.
Paul Ainsworth
Director at Sterne Kessler Goldstein & Fox
Paul Ainsworth is a Director at Sterne Kessler Goldstein & Fox.
Ricardo Camposanto
Counsel at Axinn Veltrop Harkrider LLP
Ricardo Camposanto is Counsel at Axinn Veltrop Harkrider LLP.
Rob Rodrigues
Partner at RNA Law
Rob Rodrigues is a Partner at RNA Law.
Roy Issac
Senior Intellectual Property Counsel at Bristol Myers Squibb
Roy Issac serves as Senior Intellectual Property Counsel at Bristol Myers Squibb.
Ruud Van der Velden
Partner at Hogan Lovells LLP
Ruud Van der Velden is a Partner at Hogan Lovells LLP.
Ryan Johnson
Partner at Fenwick & West LLP
Ryan Johnson is a Partner at Fenwick & West LLP.
Samantha Wilson
Partner at Young Conaway Stargatt & Taylor, LLP
Samantha Wilson is a Partner at Young Conaway Stargatt & Taylor, LLP.
Scott R. Boalick
Former Chief Administrative Patent Judge at Patent Trial and Appeal Board, U.S. Patent and Trademark Office
Scott Boalick served as the Chief Administrative Patent Judge at the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office.
Sean McGowan
SVP, Biosciences at Amneal Pharmaceuticals
Sean McGowan is the Senior Vice President of Biosciences at Amneal Pharmaceuticals.
Shashank Upadhye
Partner at Upadhye Tang LLP
Shashank Upadhye is a Partner at Upadhye Tang LLP.
Stephanie Donahue
Head of Global Patent Litigation, Global Intellectual Property Department, Legal, Ethics & Business Integrity at Sanofi
Stephanie Donahue leads Global Patent Litigation in the Global Intellectual Property Department at Sanofi.
Tedd Van Buskirk
Senior Director, IPM at MSN Pharmaceuticals
Tedd Van Buskirk is the Senior Director of IPM at MSN Pharmaceuticals.
Terry Rea
Consultant at Rea Consulting LLC
Terry Rea is a Consultant at Rea Consulting LLC.
Thomas Lavery
Senior Patent Litigation Counsel at Sandoz
Thomas Lavery is the Senior Patent Litigation Counsel at Sandoz, a global leader in generic pharmaceuticals.
Tom Irving
Senior Partner at The Marbury Law Group PLLC
Tom Irving is a Senior Partner at The Marbury Law Group PLLC.
Vishal Gupta
Partner at Steptoe LLP
Vishal Gupta is a Partner at Steptoe LLP.
Event Details
- Date
- October 17-18, 2022
- 2 days
- Location
- 🇺🇸 New York, United States
- The Times Center
- Pricing
- Varies by tier
- Audience
- Patent attorneys and litigators representing brand-name and generic pharmaceutical companies, as well as biopharmaceutical companies.
- CLE Credits
- Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.
- Attendees
- 3,700+